Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Repeat Germline Testing | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Repeat Germline Testing | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer | New policy |
| Aug 2, 2026 | CGS Administrators | Immune Thrombocytopenia (ITP) Therapy | Codes changed |
| Aug 2, 2026 | CGS Administrators | Immune Thrombocytopenia (ITP) Therapy | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Blood Product Molecular Antigen Typing | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Blood Product Molecular Antigen Typing | New policy |
| Aug 2, 2026 | CGS Administrators | Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF) | Codes changed |
| Aug 2, 2026 | CGS Administrators | Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF) | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Pigmented Lesion Assay | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Pigmented Lesion Assay | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Next-Generation Sequencing for Solid Tumors | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Next-Generation Sequencing for Solid Tumors | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Plasma-Based Genomic Profiling in Solid Tumors | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Melanoma Risk Stratification Molecular Testing | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Melanoma Risk Stratification Molecular Testing | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Envisiaâ¢, Veracyteâ¢, Idiopathic Pulmonary Fibrosis Diagnostic Test | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Envisiaâ¢, Veracyteâ¢, Idiopathic Pulmonary Fibrosis Diagnostic Test | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Inivataâ¢, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Inivataâ¢, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Breast Cancer Index® (BCI) Gene Expression Test | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Breast Cancer Index® (BCI) Gene Expression Test | New policy |
| Aug 2, 2026 | CGS Administrators | Magnetic Resonance Guided Focused Ultrasound Surgery System (MRgFUS) for the treatment of neurologic conditions | Codes changed |
| Aug 2, 2026 | CGS Administrators | Magnetic Resonance Guided Focused Ultrasound Surgery System (MRgFUS) for the treatment of neurologic conditions | New policy |
| Aug 2, 2026 | CGS Administrators | MDS FISH | Codes changed |
| Aug 2, 2026 | CGS Administrators | MDS FISH | New policy |
| Aug 2, 2026 | CGS Administrators | Cystatin C Measurement | Codes changed |
| Aug 2, 2026 | CGS Administrators | Cystatin C Measurement | New policy |
| Aug 2, 2026 | CGS Administrators | Micro-Invasive Glaucoma Surgery (MIGS) | Codes changed |
| Aug 2, 2026 | CGS Administrators | Micro-Invasive Glaucoma Surgery (MIGS) | New policy |
| Aug 2, 2026 | CGS Administrators | Frequency of Hemodialysis | Codes changed |
| Aug 2, 2026 | CGS Administrators | Frequency of Hemodialysis | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: EndoPredict Breast Cancer Gene Expression Test | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: EndoPredict Breast Cancer Gene Expression Test | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Prometheus IBD sgi Diagnostic® Policy | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Prometheus IBD sgi Diagnostic® Policy | New policy |
| Aug 2, 2026 | CGS Administrators | Chiropractic Services | Codes changed |
| Aug 2, 2026 | CGS Administrators | Chiropractic Services | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: DecisionDx-UM (Uveal Melanoma) | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: DecisionDx-UM (Uveal Melanoma) | New policy |
| Aug 2, 2026 | CGS Administrators | Coenzyme Q10 (CoQ10) | Codes changed |
| Aug 2, 2026 | CGS Administrators | Coenzyme Q10 (CoQ10) | New policy |
| Aug 2, 2026 | CGS Administrators | Bladder/Urothelial Tumor Markers | Codes changed |
| Aug 2, 2026 | CGS Administrators | Bladder/Urothelial Tumor Markers | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Healthâ¢) | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Healthâ¢) | New policy |